Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Artrya Limited ( (AU:AYA) ) has shared an announcement.
Artrya Limited has released its Corporate Governance Statement for 2025, detailing its adherence to the ASX Corporate Governance Council’s principles and recommendations. The company has decided against forming individual board committees due to its current size and operational scope, opting instead for the full board to handle these responsibilities. This approach reflects the board’s confidence in its collective expertise and is intended to optimize resource allocation. The statement also highlights the company’s commitment to transparency and accountability through its board charter and diversity policy.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on coronary artery disease detection and management. The company provides innovative medical solutions aimed at improving patient outcomes and healthcare efficiency.
Average Trading Volume: 676,761
Technical Sentiment Signal: Buy
Current Market Cap: A$414.7M
For detailed information about AYA stock, go to TipRanks’ Stock Analysis page.